Cytoreductive Surgery in Ovarian Cancer: Why, When, and How? - Wikidata - wikimedia - TriplyDB

Cytoreductive Surgery in Ovarian Cancer: Why, When, and How?

Cytoreductive Surgery in Ovarian Cancer: Why, When, and How?

http://www.wikidata.org/entity/Q30866485

about

Secondary cytoreductive surgery for recurrent epithelial ovarian carcinoma: proposal for patients selection.

P2860

Q36616507-C1210270-C149-4154-AA86-3438D92F1967

P2860

Cytoreductive Surgery in Ovarian Cancer: Why, When, and How?

http://www.wikidata.org/entity/Q30866485

description

1996 nî lūn-bûn

@nan

1996 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

1996 թվականի մարտին հրատարակված գիտական հոդված

@hy

1996年の論文

@ja

1996年論文

@yue

1996年論文

@zh-hant

1996年論文

@zh-hk

1996年論文

@zh-mo

1996年論文

@zh-tw

1996年论文

@wuu

name

Cytoreductive Surgery in Ovarian Cancer: Why, When, and How?

@ast

Cytoreductive Surgery in Ovarian Cancer: Why, When, and How?

@en

type

label

Cytoreductive Surgery in Ovarian Cancer: Why, When, and How?

@ast

Cytoreductive Surgery in Ovarian Cancer: Why, When, and How?

@en

prefLabel

Cytoreductive Surgery in Ovarian Cancer: Why, When, and How?

@ast

Cytoreductive Surgery in Ovarian Cancer: Why, When, and How?

@en

P1433

Q30866485-EC48B891-040F-4558-9656-A0666F4F1023

P1476

Q30866485-79E4A4B9-F04D-4183-BA00-7F9EF6B985D9

P2093

Q30866485-F130A64F-1A9F-4C0F-B47D-7BF38FD6D393

P2860

Q30866485-0487FF7D-C51F-4323-9207-40EAEA4B2682

Q30866485-0939E615-5B95-4F37-AED4-4D2E1687D4DA

Q30866485-272C06C1-13F2-4983-BA85-9EECC6356391

Q30866485-316B3548-C68E-4577-9657-7A3ACA69892D

Q30866485-3D4B284E-90D2-4C00-8152-2C552CF455A0

Q30866485-6E65F013-8429-442D-B4DC-8E956A1F51DF

Q30866485-6FEFF64D-2100-4B1F-B333-B4AAD32EB80D

Q30866485-9521F504-1B45-499F-9D24-8F559EDF2354

Q30866485-9564507F-B925-4D6B-8A2E-2C8E0897782B

Q30866485-A7FE6394-6EFA-4B0E-8F4D-84599F27E9B1

P304

Q30866485-038F23FC-622E-4269-9595-E649F23B84CA

P31

Q30866485-6668D075-F46E-42DC-912B-C87AEB49C82A

P356

Q30866485-8CE543A9-E6DB-469D-84D2-8BE79CF479C6

P433

Q30866485-14F24E2C-EBF1-49E0-AB55-F4F257E64FE2

P478

Q30866485-2FAD0673-B63F-470D-BDA2-FCE1F0F3CA56

P577

Q30866485-B091DC7C-A178-4A1A-AB89-2BB34043B34C

P698

Q30866485-D5AE3198-6FF1-4DBA-BCB8-701AEA6BED42

P921

Q30866485-03C3F898-C656-4A26-9EA0-1161D6BCE574

P356

107327489600300205

P1433

P1476

Cytoreductive Surgery in Ovarian Cancer: Why, When, and How?

@en

P2093

Roberts WS

http://www.w3.org/2001/XMLSchema#string

P2860

Cis-platin based combination chemotherapy for advanced ovarian cancer. High overall response rate with curative potential only in women with small tumor burdens.

The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume stage III epithelial ovarian cancer: a Gynecologic Oncology Group study.

The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. Gynecological Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer.

Peritoneal implant elimination during cytoreductive surgery for ovarian cancer: impact on survival.

Epithelial ovarian carcinoma: principles of primary surgery.

Reverse hysterocolposigmoidectomy (RHCS) for resection of panpelvic tumors.

Randomised trial comparing two combination chemotherapy regimens (Hexa-CAF vs CHAP-5) in advanced ovarian carcinoma.

Radical surgical procedure improves survival time in patients with recurrent ovarian cancer.

Failure of second-look laparotomy to influence survival in epithelial ovarian cancer.

Electrosurgical debulking of ovarian cancer: a new technique using the argon beam coagulator.

P304

130-136

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/107327489600300205

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

1996-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10792873

http://www.w3.org/2001/XMLSchema#string

P921